These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3512593)

  • 41. Unexplained increase in serum corticosteroid-binding globulin levels in a patient with chronic thyroiditis, pituitary adenoma and empty sella.
    Tojo K; Ohno Y; Kawamura M; Sakai O
    Endocr J; 1996 Dec; 43(6):665-70. PubMed ID: 9075606
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Circulating nitric oxide changes throughout the menstrual cycle in healthy women and women affected by pathological hyperprolactinemia on dopamine agonist therapy.
    Giusti M; Fazzuoli L; Cavallero D; Valenti S
    Gynecol Endocrinol; 2002 Oct; 16(5):407-12. PubMed ID: 12587536
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional studies of dopamine control of prolactin secretion in normal women and women with hyperprolactinemic pituitary microadenoma.
    Quigley ME; Judd SJ; Gilliland GB; Yen SS
    J Clin Endocrinol Metab; 1980 Jun; 50(6):994-8. PubMed ID: 7372794
    [No Abstract]   [Full Text] [Related]  

  • 44. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
    Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The inhibitory effect of dopamine agonists on LH release in women.
    Lachelin GC; Leblanc H; Yen SS
    J Clin Endocrinol Metab; 1977 Apr; 44(4):728-32. PubMed ID: 576612
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Usefulness of determining serum levels of prolactin in women with menstruation disorders].
    Starzewski J; Niespodziański K; Kowalski D; Kowalska K; Piasek G; Chlewicka B
    Przegl Lek; 1989; 46(10):728-31. PubMed ID: 2594991
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pituitary adenocarcinoma in an acromegalic patient: response to bromocriptine and pituitary testing: a review of the literature on 36 cases of pituitary carcinoma.
    Mountcastle RB; Roof BS; Mayfield RK; Mordes DB; Sagel J; Biggs PJ; Rawe SE
    Am J Med Sci; 1989 Aug; 298(2):109-18. PubMed ID: 2669475
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Successful pregnancies in patients with hyperprolactinemia--clinical and endocrinological studies on mothers and babies.
    Goto T; Narita O; Suganuma N; Suzuki M; Tomoda Y; Kuwayama A; Kageyama N
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Apr; 35(4):550-8. PubMed ID: 6854101
    [TBL] [Abstract][Full Text] [Related]  

  • 49. O-methylguanine-DNA methyltransferase immunoexpression in a double pituitary adenoma: case report.
    Mohammed S; Cusimano MD; Scheithauer BW; Rotondo F; Horvath E; Kovacs K
    Neurosurgery; 2010 Feb; 66(2):E421-2; discussion E422. PubMed ID: 20087113
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy.
    Di Sarno A; Landi ML; Cappabianca P; Di Salle F; Rossi FW; Pivonello R; Di Somma C; Faggiano A; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5256-61. PubMed ID: 11701688
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
    Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metergoline and bromocriptine in the management of tumoral and idiopathic hyperprolactinemia.
    Falsetti L; Roggia A; Loda G; Turla R; Scagliola T; Schimberni M; Pontiroli AE
    Horm Metab Res; 1983 Aug; 15(8):380-4. PubMed ID: 6618428
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Twenty-four hour secretory pattern of thyroid-stimulating hormone in hyperprolactinemic women with pituitary microadenoma.
    Seki K; Uesato T; Kato K; Shima K
    Endocrinol Jpn; 1985 Jun; 32(3):369-73. PubMed ID: 4042992
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Inhibition of prolactin release by methysergide and bromocriptine in hyperprolactinemic subjects: comparative dynamic studies (author's transl)].
    Fossati P; Dewailly D; Lemaire A; Cappoen JP; Wemeau JL; Fourlinnie JC; Linquette M
    Ann Endocrinol (Paris); 1980; 41(1):55-6. PubMed ID: 7396395
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Medical treatment of hyperprolactinemia.
    Fossati P; Dewailly D; Thomas-Desrousseaux P; Buvat J; Fermon C; Lemaire A; Bourdelle-Hego MF; Pouyol-Motte H; Lemaitre G; Clarisse J
    Horm Res; 1985; 22(3):228-38. PubMed ID: 4054843
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypothalamo-pituitary dopaminergic system in patients with myotonic dystrophy.
    Sakuma H; Takase S; Mizuno Y; Teramura K; Hanew K
    Tohoku J Exp Med; 1988 Nov; 156(3):291-8. PubMed ID: 3252557
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mosaic Turner's syndrome and pituitary microadenoma.
    Gáspár L; Julesz J; Kocsis J; Pásztor E; László F
    Exp Clin Endocrinol; 1985 Aug; 86(1):87-92. PubMed ID: 4054225
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Which treatment for hyperprolactinemic females?
    Strauch G
    Horm Res; 1985; 22(3):215-21. PubMed ID: 4054841
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment with hachimijiogan, a non-ergot Chinese herbal medicine, in two hyperprolactinemic infertile women.
    Usuki S; Kubota S; Usuki Y
    Acta Obstet Gynecol Scand; 1989; 68(5):475-8. PubMed ID: 2520800
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of single and combined tests for the evaluation of plasma growth hormone secretion in normal short children.
    Bazán MC; Domené H; Heinrich JJ; Barontini M; Bergadá C
    J Endocrinol Invest; 1984 Aug; 7(4):295-8. PubMed ID: 6389660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.